Blog
RSS FeedPosted by Michael Wonder on 25 Sep 2020
FDA takes actions to help lower U.S. prescription drug prices
24 September 2020 - Final rule, guidance fulfil plan for safe importation of certain drugs originally intended for foreign markets. ...
Posted by Michael Wonder on 15 Aug 2020
Valuing innovative drugs based on their cost of manufacturing will prolong the COVID-19 pandemic
14 August 2020 - The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, ...
Posted by Michael Wonder on 05 Aug 2020
Moderna is pricing coronavirus vaccine at $32 to $37 per dose for some customers
5 August 2020 - The company defines a small order of its vaccine as “in the millions.” ...
Posted by Michael Wonder on 29 Jul 2020
Moderna pitches virus vaccine at about $50-$60 per course
29 July 2020 - Price charged to governments would be higher than that agreed for rival jabs from Pfizer and BioNTech. ...
Posted by Michael Wonder on 22 Jul 2020
Pfizer vaccine deal at $20 a dose sets ceiling for rivals
22 July 2020 - U.S. agrees to pay Pfizer, BioNTech $1.95 billion on approval. ...
Posted by Michael Wonder on 22 Jul 2020
Coronavirus: pharmaceutical giants split on vaccine profits
22 July 2020 - Pharmaceutical companies are split on how they would price their potential COVID-19 vaccines, with some pledging ...
Posted by Michael Wonder on 06 Jul 2020
Will we be hostages to drug makers’ Covid vaccine pricing?
6 July 2020 - The United States is the only developed nation unable to balance cost, efficacy and social good in ...
Posted by Michael Wonder on 29 Jun 2020
Gilead sets price for coronavirus drug remdesivir at $2,340, sparking criticism
30 June 2020 - The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says ...
Posted by Michael Wonder on 16 Jun 2020
Supreme Court will not hear generic drug price fixing discovery dispute
16 June 2020 - The U.S. Supreme Court on Monday declined to hear generic drug makers’ challenge to a court ...
Posted by Michael Wonder on 10 Jun 2020
Price limits will scare off COVID-19 vaccine makers, Fauci warns
10 June 2020 - More than one vaccine will be needed, Fauci says. ...
Posted by Michael Wonder on 09 Jun 2020
The coronavirus pandemic is reigniting a fierce debate over compounded drugs
9 June 2020 - In hopes of alleviating potential drug shortages and other issues wrought by the coronavirus pandemic, the ...
Posted by Michael Wonder on 28 May 2020
Tax payers paid to develop remdesivir but will have no say when Gilead sets the price
27 May 2020 - Critics say government deserves more credit for tens of millions in public money spent to develop coronavirus ...
Posted by Michael Wonder on 21 May 2020
Coronavirus revives debate over drug pricing
21 May 2020 - Lure of profits laid groundwork for some COVID-19 treatments, though may not determine who finds a cure. ...
Posted by Michael Wonder on 18 May 2020
Beware of underpriced drugs for COVID-19 treatments
18 May 2020 - It has become painfully obvious that the only path back to normalcy involves either an effective ...
Posted by Michael Wonder on 17 May 2020
Less than a movie ticket or ‘impossible to overpay’? Experts name their price for remdesivir
15 May 2020 - Two weeks ago, the world learned that remdesivir, a treatment from Gilead Sciences, has a moderate ...